Jung-Min Lee Selected Research

Platinum

5/2024	A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
3/2024	The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.
1/2023	Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
11/2022	A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer.
10/2022	Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial.
10/2020	PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline.
1/2020	Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study.
12/2019	New strategies in ovarian cancer treatment.
11/2018	Update on PARP Inhibitors in Breast Cancer.
2/2016	Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung-Min Lee Research Topics

Disease

37	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 05/2013
31	Neoplasms (Cancer) 05/2024 - 01/2014
7	Insulin Resistance 01/2023 - 06/2011
6	Thrombocytopenia (Thrombopenia) 11/2022 - 06/2006
6	Neutropenia 11/2022 - 05/2013
5	Foot-and-Mouth Disease 12/2020 - 11/2017
4	Carcinoma (Carcinomatosis) 03/2024 - 01/2018
4	Triple Negative Breast Neoplasms 10/2023 - 10/2017
4	Fatigue 11/2022 - 05/2013
4	Hypertension (High Blood Pressure) 12/2018 - 04/2013
3	Breast Neoplasms (Breast Cancer) 10/2023 - 11/2018
3	Infections 05/2023 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2023 - 04/2013
3	Body Weight (Weight, Body) 01/2021 - 01/2004
2	Wounds and Injuries (Trauma) 03/2024 - 01/2021
2	Ovarian Epithelial Carcinoma 01/2024 - 02/2016
2	Whooping Cough (Pertussis) 05/2023 - 03/2017
2	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 11/2014
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023 - 12/2020
2	Heart Failure 01/2023 - 07/2018
2	Anemia 11/2022 - 12/2020
2	Nausea 11/2022 - 09/2011
2	Genomic Instability 02/2022 - 10/2020
2	Hypersensitivity (Allergy) 01/2022 - 05/2013
2	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 12/2018
2	Disease Progression 01/2020 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2020 - 10/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2018 - 01/2014
2	Dyspnea (Shortness of Breath) 07/2018 - 09/2011
2	Asthma (Bronchial Asthma) 02/2016 - 09/2015
2	Pancreatitis 05/2013 - 06/2006
2	Hypercholesterolemia 04/2013 - 12/2011
1	Arthritis (Polyarthritis) 03/2024
1	Sleep Wake Disorders 03/2024
1	Human Influenza (Influenza) 12/2023
1	Frailty 11/2023
1	Hyperthyroidism 11/2023
1	Hypothyroidism 11/2023
1	Endometrial Neoplasms (Endometrial Cancer) 10/2023
1	Hepatitis B 05/2023
1	Diphtheria 05/2023
1	Communicable Diseases (Infectious Diseases) 05/2023
1	Tetanus 05/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Bloom Syndrome 01/2023

Drug/Important Bio-Agent (IBA)

18	olaparibIBA 05/2024 - 06/2014
18	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 01/2014
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2014
12	PlatinumIBA 05/2024 - 10/2014
9	cediranib (AZD2171)IBA 05/2024 - 10/2014
8	prexasertibIBA 03/2024 - 12/2017
7	VaccinesIBA 05/2023 - 01/2014
6	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2019
6	durvalumabIBA 12/2021 - 07/2017
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2012
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2016
5	Phosphotransferases (Kinase)IBA 12/2020 - 12/2017
5	Carboplatin (JM8)FDA LinkGeneric 04/2019 - 06/2014
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 01/2015
4	Insulin (Novolin)FDA Link 01/2021 - 06/2011
3	AntigensIBA 03/2023 - 01/2020
2	TabletsIBA 05/2024 - 03/2017
2	Hormones (Hormone)IBA 03/2024 - 10/2023
2	Death Domain ReceptorsIBA 10/2023 - 01/2023
2	Combined VaccinesIBA 05/2023 - 11/2017
2	Monoclonal AntibodiesIBA 04/2023 - 03/2023
2	Polysaccharides (Glycans)IBA 04/2023 - 03/2023
2	RecQ HelicasesIBA 01/2023 - 02/2022
2	LipidsIBA 01/2023 - 04/2013
2	AdiponectinIBA 11/2022 - 04/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2018
2	AntibodiesIBA 12/2020 - 01/2019
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2020 - 05/2013
2	Bevacizumab (Avastin)FDA Link 10/2020 - 10/2020
2	B7-H1 AntigenIBA 01/2019 - 07/2017
2	rucaparibIBA 11/2018 - 12/2017
2	Parathyroid Hormone (Parathormone)IBA 01/2018 - 01/2017
2	Vitamin D FDA LinkGeneric 01/2018 - 01/2017
2	OvalbuminIBA 02/2016 - 09/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 01/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2024
1	MelatoninIBA 03/2024
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023
1	LigandsIBA 10/2023
1	TIC10 compoundIBA 10/2023
1	pembrolizumabIBA 03/2023
1	Immunoglobulin G (IgG)IBA 03/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023

Therapy/Procedure

23	Therapeutics 01/2024 - 04/2013
4	Immunotherapy 01/2023 - 01/2020
2	Percutaneous Coronary Intervention 01/2023 - 06/2006
2	Castration 12/2021 - 12/2018
2	Drug Therapy (Chemotherapy) 10/2020 - 11/2018
1	Osteotomy 03/2024